Independent Director · ZEVRA THERAPEUTICS, INC. (ZVRA)

Alvin Shih, M.D — ZEVRA THERAPEUTICS Director Compensation (2025)

Fiscal year 2025 director compensation for Alvin Shih, M.D at ZEVRA THERAPEUTICS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 20, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

ZEVRA THERAPEUTICS Director Compensation Table · the one fiscal year held
In US dollars, as ZEVRA THERAPEUTICS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$57,500—$187,178—$244,678

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ZEVRA THERAPEUTICS, INC. DEF 14A filed April 20, 2026, accession 0001434647-26-000025, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

ZEVRA THERAPEUTICS pays directors a $45,000 cash retainer.

The rest of the ZEVRA THERAPEUTICS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alicia SecorIndependent Director$264,878
Corey WattonIndependent Director$249,678
Douglas W. CalderIndependent Director$243,992
John B. BodeIndependent Director$246,913
Tamara A. FavoritoChair of the Board$304,678
Thomas D. AndersonIndependent Director$252,178

The full ZEVRA THERAPEUTICS compensation record

free company brief

This page is one director within ZEVRA THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy